title: Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia.
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy. Electronic address: sara.galimberti@med.unipi.it.
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Fontanelli
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Barsotti
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Ricci
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Guerrini
authors.affiliation: Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy.
authors.forename: Claudia
authors.initials: C
authors.lastname: Baratè
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D020574:Proto-Oncogene Proteins c-sis / Q000378:metabolism*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000097:blood*; D013375:Substance Withdrawal Syndrome / Q000097:blood* / Q000209:etiology
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D020574:Proto-Oncogene Proteins c-sis; D011505:Protein-Tyrosine Kinases; D020797:Receptor, Platelet-Derived Growth Factor beta